Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma

doi:10.4254/wjh.v6.i9.670

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5654)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

358

WORD

278

HTML

2768

Figures (1-1)

127

Tables (1-4)

142

Sum=3673

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

886

Download

1095

Sum=1981

Sep 27, 2014 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Sep 27, 2014; 6(9): 670-676
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.670

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival and skin toxicity. Kaplan-Meier curve shows that patients with over grade 2 skin toxicity could live longer. Thus more severe skin toxicity is associated with longer survival.

Citation: Shomura M, Kagawa T, Shiraishi K, Hirose S, Arase Y, Koizumi J, Mine T. Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma. World J Hepatol 2014; 6(9): 670-676
URL: https://www.wjgnet.com/1948-5182/full/v6/i9/670.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i9.670